ClinicalTrials.gov
ClinicalTrials.gov Menu

Swiss Transplant Cohort Study (STCS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01204944
Recruitment Status : Recruiting
First Posted : September 17, 2010
Last Update Posted : January 4, 2017
Sponsor:
Collaborators:
University of Bern
University of Basel
University of Lausanne
Cantonal Hospital of St. Gallen
University Hospital, Geneva
Information provided by (Responsible Party):
Nicolas Mueller, University of Zurich

Brief Summary:
The Swiss Transplant Cohort Study is an observational prospective cohort study enrolling all patients after solid organ and stem cell transplantation since 5/2008 in Switzerland. Predefined variables are collected at defined time points. Individual samples (PBMC, plasma, DNA) will be stored for future projects. Data relevant to transplantation outcome with emphasis on immunological and infectious complications as well as psychosocial variables will be gathered.

Condition or disease
All Transplanted Individuals in Switzerland

Study Type : Observational
Estimated Enrollment : 7500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Swiss Transplant Cohort Study
Study Start Date : May 2008
Estimated Primary Completion Date : May 2018
Estimated Study Completion Date : May 2018



Primary Outcome Measures :
  1. Outcome after transplantation [ Time Frame: open ]
    Various endpoints



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All transplanted indivduals in Switzerland
Criteria

Inclusion criteria:

  • All patients after organ and stem cell (planned 2009) transplantation.

Exclusion criteria:

  • No informed consent given

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01204944


Contacts
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Locations
Switzerland
Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
University of Bern
University of Basel
University of Lausanne
Cantonal Hospital of St. Gallen
University Hospital, Geneva
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich

Responsible Party: Nicolas Mueller, Head, Zurich University Hospital Transplant Center, University of Zurich
ClinicalTrials.gov Identifier: NCT01204944     History of Changes
Other Study ID Numbers: 3347C0-108795/1
First Posted: September 17, 2010    Key Record Dates
Last Update Posted: January 4, 2017
Last Verified: January 2017